nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—embryo—muscle cancer	0.0543	0.104	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Doxorubicin—muscle cancer	0.0514	1	CbGdCrCtD
Masoprocol—IGF1R—smooth muscle tissue—muscle cancer	0.0427	0.0822	CbGeAlD
Masoprocol—IGF1R—renal system—muscle cancer	0.0411	0.0791	CbGeAlD
Masoprocol—LTB4R—bone marrow—muscle cancer	0.0377	0.0724	CbGeAlD
Masoprocol—LTB4R—vagina—muscle cancer	0.0361	0.0694	CbGeAlD
Masoprocol—LTB4R—testis—muscle cancer	0.0322	0.0619	CbGeAlD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—IGF2—muscle cancer	0.0314	0.0731	CbGpPWpGaD
Masoprocol—IGF1R—vagina—muscle cancer	0.0298	0.0573	CbGeAlD
Masoprocol—IGF1R—head—muscle cancer	0.0275	0.0529	CbGeAlD
Masoprocol—IGF1R—Apoptosis—TP73—muscle cancer	0.0267	0.0624	CbGpPWpGaD
Masoprocol—IGF1R—testis—muscle cancer	0.0266	0.0511	CbGeAlD
Masoprocol—CYP2J2—cardiac atrium—muscle cancer	0.025	0.048	CbGeAlD
Masoprocol—IGF1R—Apoptosis—TP63—muscle cancer	0.023	0.0536	CbGpPWpGaD
Masoprocol—ALOX5—smooth muscle tissue—muscle cancer	0.0228	0.0439	CbGeAlD
Masoprocol—CYP2J2—tendon—muscle cancer	0.0218	0.0419	CbGeAlD
Masoprocol—IGF1R—Endochondral Ossification—PTCH1—muscle cancer	0.0214	0.05	CbGpPWpGaD
Masoprocol—CYP2J2—vagina—muscle cancer	0.0202	0.0388	CbGeAlD
Masoprocol—CYP2J2—head—muscle cancer	0.0186	0.0359	CbGeAlD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—IGF2—muscle cancer	0.0186	0.0434	CbGpPWpGaD
Masoprocol—CYP2J2—testis—muscle cancer	0.018	0.0347	CbGeAlD
Masoprocol—ALOX5—bone marrow—muscle cancer	0.0166	0.0319	CbGeAlD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—FOXO4—muscle cancer	0.0151	0.0352	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—IGF2—muscle cancer	0.0148	0.0345	CbGpPWpGaD
Masoprocol—ALOX5—head—muscle cancer	0.0147	0.0283	CbGeAlD
Masoprocol—ALOX5—testis—muscle cancer	0.0142	0.0273	CbGeAlD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—HMGA1—muscle cancer	0.0138	0.0322	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—IGF2—muscle cancer	0.0119	0.0277	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IGF2—muscle cancer	0.0114	0.0265	CbGpPWpGaD
Masoprocol—ALOX5—Eicosanoid Synthesis—PTGS2—muscle cancer	0.0113	0.0263	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—FOXO1—muscle cancer	0.0112	0.026	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IGF2—muscle cancer	0.0111	0.0258	CbGpPWpGaD
Masoprocol—CYP19A1—head—muscle cancer	0.0102	0.0195	CbGeAlD
Masoprocol—CYP19A1—testis—muscle cancer	0.00981	0.0189	CbGeAlD
Masoprocol—CYP19A1—FSH signaling pathway—FOXO1—muscle cancer	0.00914	0.0213	CbGpPWpGaD
Masoprocol—CYP2J2—Tryptophan metabolism—MDM2—muscle cancer	0.0078	0.0182	CbGpPWpGaD
Masoprocol—CYP2J2—Arachidonic acid metabolism—PTGS2—muscle cancer	0.00704	0.0164	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.00697	0.0163	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CDKN2A—muscle cancer	0.0069	0.0161	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—CDKN2A—muscle cancer	0.00677	0.0158	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—VEGFA—muscle cancer	0.00671	0.0156	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—MDM2—muscle cancer	0.00669	0.0156	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—MDM2—muscle cancer	0.00657	0.0153	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—FOXO1—muscle cancer	0.00653	0.0152	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—VEGFA—muscle cancer	0.00628	0.0146	CbGpPWpGaD
Masoprocol—ALOX5—Arachidonic acid metabolism—PTGS2—muscle cancer	0.00627	0.0146	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—VEGFA—muscle cancer	0.0062	0.0145	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.00597	0.0139	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—PTGS2—muscle cancer	0.00567	0.0132	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—CDKN2A—muscle cancer	0.00566	0.0132	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—MDM2—muscle cancer	0.00549	0.0128	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—PTCH1—muscle cancer	0.00539	0.0126	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CNR1—muscle cancer	0.00455	0.0106	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KIDINS220—muscle cancer	0.00415	0.00968	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—PTGS2—muscle cancer	0.00399	0.00931	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—TP53—muscle cancer	0.00384	0.00896	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TP53—muscle cancer	0.00377	0.00879	CbGpPWpGaD
Masoprocol—CYP19A1—Tryptophan metabolism—MDM2—muscle cancer	0.00358	0.00836	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KIDINS220—muscle cancer	0.00353	0.00823	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TP53—muscle cancer	0.00338	0.00787	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.00317	0.00739	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TP53—muscle cancer	0.00315	0.00735	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.00282	0.00658	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PTCH1—muscle cancer	0.00276	0.00645	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—VEGFA—muscle cancer	0.0026	0.00605	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CNR1—muscle cancer	0.00257	0.00599	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—FH—muscle cancer	0.0025	0.00582	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CNR1—muscle cancer	0.00233	0.00544	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.00231	0.00538	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—FH—muscle cancer	0.00222	0.00519	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTCH1—muscle cancer	0.00163	0.00381	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.00145	0.00339	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MED12—muscle cancer	0.00141	0.00329	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FOXO4—muscle cancer	0.0014	0.00328	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTCH1—muscle cancer	0.00139	0.00324	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.00138	0.00323	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CNR1—muscle cancer	0.00138	0.00322	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ENO2—muscle cancer	0.00129	0.003	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MED12—muscle cancer	0.00126	0.00293	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FOXO4—muscle cancer	0.00119	0.00279	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CNR1—muscle cancer	0.00117	0.00273	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ENO2—muscle cancer	0.00115	0.00267	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—FH—muscle cancer	0.00115	0.00267	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF2—muscle cancer	0.00113	0.00263	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	0.00105	0.00245	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FOXO1—muscle cancer	0.00104	0.00242	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.00101	0.00235	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF2—muscle cancer	0.000958	0.00224	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000896	0.00209	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FOXO1—muscle cancer	0.000882	0.00206	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—muscle cancer	0.000794	0.00185	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KIT—muscle cancer	0.00079	0.00184	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KIT—muscle cancer	0.000672	0.00157	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MED12—muscle cancer	0.000648	0.00151	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MDM2—muscle cancer	0.000622	0.00145	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ENO2—muscle cancer	0.00059	0.00138	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MDM2—muscle cancer	0.000529	0.00123	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—muscle cancer	0.000473	0.0011	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000462	0.00108	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—muscle cancer	0.000448	0.00104	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—muscle cancer	0.000402	0.000937	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—muscle cancer	0.000399	0.000931	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—muscle cancer	0.000357	0.000833	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—muscle cancer	0.000304	0.000708	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—muscle cancer	0.000206	0.00048	CbGpPWpGaD
